Vyhledávání publikací

Vybrané publikace/výsledky

Optimizing of bone marrow- and adipose tissue-derived mesenchymal stromal cells manufacturing for clinical trials according to GMP guidelines (2010)
Podmínky správné výrobní praxe (Good Manufacturing Practice -GMP) v čistých prostorách Masarykovy univerzity (2011)
Nestin expression throughout multistep pathogenesis of multiple myeloma (2014)
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse (2014)
High-Risk Multiple Myeloma: Different Definitions, Different Outcomes? (2014)
Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma (2014)
Cytokinové profily mnohočetného myelomu a Waldenströmovy makroglobulinemie (2014)
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance (2014)
Detection of tumor-specific marker for minimal residual disease in multiple myeloma patients (2015)
The miR-29 family in hematological malignancies (2015)
Detekce hereditárních amyloidóz (2014)
Impact of Anakinra Treatment on Cytokine and Lymphocytes/ Monocytes Profile of an Erdheim-Chester Patient (2014)
CIRKULUJÍCÍ MIR-130a JAKO MARKER EXTRAMEDULÁRNÍHO RELAPSU MNOHOČETNÉHO MYELOMU (2014)
Cirkulující MIR-34a a MIR-130a jako biomarkery extramedulární formy mnohočetného myelomu (2014)
CIRCULATING MIR-34a AND MIR-130a AS BIOMARKERS OF EXTRAMEDULLARY DISEASE (2014)
Cereblon - nový terapeutický ciel' v liečbe mnohopočetného myelómu (2014)
Monoklonální gamapatie nejistého významu a asymptomatický mnohočetný myelom z pohledu roku 2014 (2014)
Diagnostika a léčba Waldenströmovy makroglobulinemie (2014)
Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist - an initial in vitro study (2014)
Combination of serum microRNA-320a and microRNA-320b as a marker for Waldenström macroglobulinemia (2015)
Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients (2014)
Circulating MiR-130a monitoring in multiple myeloma patients and patients with extramedullary disease (2014)
Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data (2015)
Detekce minimální residuální choroby ze séra pacientů s mnohočetným myelomem (2015)
Cirkulující sérová miR-130a jako marker extramedulárního relapsu mnohočetného myelomu (2015)
Cirkulující mikroRNA v moči u mnohočetného myelomu (2015)
Cirkulující mikroRNA v moči jako biomarker mnohočetného myelomu (2015)
Mimobuněčná DNA u mnohočetného myelomu (2015)
Modelové systémy v molekulární medicíně (2015)
Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma (2015)
MicroRNAs in urine are not biomarkers of multiple myeloma (2015)
Cytogenetics in multiple myeloma patients progressing into extramedullary disease (2016)
Potenciál volné cirkulující DNA v diagnostice nádorových onemocnění (2015)
Scleroedema adultorum Buschke a scleromyxedema (2015)
Monoklonalní gamapatie nejasného významu s nízkým a vysokým stupněm rizika: výstupy z analýz RMG registru České myelomové skupiny pro praxi (2015)
Circulating microRNA as Biomarkers in Hematological Malignancies (2015)
Monoklonální imunoglobulin a kožní nemoci ze skupiny mucinóz - scleredema adultorum Buschke a scleromyxedema: popis 4 případů a přehled léčebných možností (2015)
Potenciál dlouhých nekódujících molekul RNA v diagnostice nádorových onemocnění (2016)
Změny v prognóze a v léčbě Waldenströmovy makroglobulinemie: přehled literatury a vlastní zkušenosti (2016)
Genetické změny u Waldenströmovy makroglobulinemie (2016)
Pacient si stěžuje na bolesti v páteři nebo na únavu a slabost. Jak rozeznám, zda je příčinou spondylartróza, věk nemocného anebo mnohočetný myelom? (2016)
Hyperkalcemie, příznaky, diferenciální diagnostika a léčba aneb důležitost vyšetřování kalcia (2016)
Detekce minimální reziduální choroby u mnohočetného myelomu pomocí mimobuněčné DNA (2016)
Detection of minimal residual disease in multiple myeloma using cell-free DNA (2015)
Long non-coding RNAs in multiple myeloma (2016)
Dlouhé nekódující RNA u mnohočetného myelomu (2016)
Hodnocení pětileté léčby Erdheimovy-Chesterovy nemoci anakinrou – kazuistika a přehled literatury (2016)
Pomalidomid v léčbě mnohočetného myelomu vlastní zkušenosti a přehled literatury (2016)
Léčba 14 případů Castlemanovy nemoci: Zkušenosti jednoho centra a přehled literatury (2016)
Schnitzlerové syndrom : Diferenciální diagnostika, přehled léčebných možností a popis 5 případů léčených anakinrou (2016)
High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma (2017)
Deregulated expression of long non-coding RNA UCA1 in multiple myeloma (2017)
Liquid Biopsies - The Clinics and the Molecules (2017)
Biobanking – the First Step to Successful Liquid Biopsy Experiments (2017)
Cell-free DNA — Minimally invasive marker of hematological malignancies (2017)
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance (2017)
Diagnosis of Multiple Myeloma by Mass Spectrometry of Peripheral Blood Plasma and Artificial Intelligence (2017)
Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients (2018)
Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients (2018)
The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets (2018)
Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies (2018)
The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple Myeloma (2018)
Analýza mikroRNA u extramedulárního relapsu mnohočetného myelomu (2018)
The impact of NF-kappa B signaling on pathogenesis and current treatment strategies in multiple myeloma (2019)
Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target? (2019)
Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma (2019)
Extramedullary disease in multiple myeloma - controversies and future directions (2019)
Long Non-Coding RNAs in Multiple Myeloma (2019)
Plazmocelulární leukémie – zapomenutá nemoc (2019)
MikroRNA u mnohočetného myelomu (2019)
Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients (2020)
MicroRNA analysis in multiple myeloma and extramedullary disease (2019)
Predicting Treatment Response of Multiple Myeloma Patients Using Tumor Specific cell-free DNA (2019)
Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data (2020)
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model (2020)
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience (2020)
Intact Cell Mass Spectrometry for Embryonic Stem Cell Biotyping (2021)
Role exozomů u nádorových onemocnění (2020)
Léčba Erdheimovy-Chesterovy choroby. (2020)
Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development (2021)
Risk Factors Associated with Development of Extramedullary Disease in Multiple Myeloma (2018)
Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant (2021)
Tumor Specific cfDNA Predicts Treatment Response of Multiple Myeloma Patients (2018)
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease (2022)
Arsenic-Doped SnSe Thin Films Prepared by Pulsed Laser Deposition (2021)
Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia (2021)
ČERNÝ FOSFOR PRO CITLIVÉ KLINICKÉ APLIKACE V HMOTNOSTNÍ SPEKTROMETRII BIOMOLEKUL (2021)
Laser ablation of Ga-Sb- Te thin films monitored with quadrupole ion trap time-of- flight mass spectrometry (2021)
Anatomie, histologie a fyziologie pankreatu (2021)
Klinická pankreatologie (2021)
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience (2021)
LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients (2021)
Identification of patients at high risk of secondary extramedullary multiple myeloma development (2022)
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data (2021)
Erdheimova-Chesterova choroba (2021)
Waldenströmova makroglobulinemie (2021)
Transformace IgM-MGUS do Waldenströmovy makroglobulinemie u 2 z 6 pacientů v průběhu léčby syndromu Schnitzlerové (2021)
Léčba tří pacientů s Erdheimovou-Chesterovou chorobou kladribinem, případně kombinací kladribinu a cyklofosfamidu a přehled léčby této nemoci (2021)
A new cotton functionalized with iron(III) trimer-like metal framework as an effective strategy for the adsorption of triarylmethane dye: An insight into the dye adsorption processes (2021)
Germanium-antimony-selenium-tellurium thin films: Clusters formation by laser ablation and comparison with clusters from mixtures of elements (2022)
Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action (2022)
Barriers in Systemic Delivery and Preclinical Testing of Synthetic microRNAs in Animal Models: an Experimental Study on miR-215-5p Mimic (2021)
Matrix enrichment by black phosphorus improves ionization and reproducibility of mass spectrometry of intact cells, peptides, and amino acids (2022)
Klastry nanozlata jako nosiče antialzheimerika Huperzinu A, Aum(Hup A)n (2021)
大腸癌の診断方法 (2021)
Historie a vědecké dědictví brněnské embryologie: od prof. Floriana k embryonálním kmenovým buňkám (2021)
Bioanalytical quality control in stem cell cultures (2022)
Combined efficacy of Cinnamomum zeylanicum and doxorubicin against leukemia through regulation of TRAIL and NF-kappa B pathways in rat model. (2022)
Expandable Lung Epithelium Differentiated from Human Embryonic Stem Cells (2022)
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas (2022)
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma (2023)
ONE STEP CHEMICAL DERIVATIZATION OF SECRETED CELL METABOLITES FOR SENSITIVE MASS SPECTROMETRY DETECTION (2022)
DERIVATIZATION STRATEGIES FOR SENSITIVE MONITORING OF SMALL MOLECULES ON TISSUE SAMPLES (2022)
Identification of molecular heterogeneity in pancreatic ductal adenocarcinoma by multivariate profiling of unfolded protein response (2022)
Immunomodulatory Agents for Multiple Myeloma (2022)
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma (2022)
Onemocnění asociované s imunoglobulinem IgG4. Klinické příznaky, diferenciální diagnostika a recentní mezinárodní diagnostická kritéria (2022)
Proteomic analysis of the bone marrow microenvironment in extramedullary multiple myeloma patients (2022)
Artificial Neural Networks Coupled with MALDI-TOF MS Serum Fingerprinting To Classify and Diagnose Pathological Pain Subtypes in Preclinical Models (2023)
Asociace tkáňové exprese miR-196a s Barrettovým jícnem a adenokarcinomem jícnu (2023)
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data (2022)
Synthesis, performance and mechanism of nanoporous Fe-(1,3,5-tricarboxylic acid) metal-organic framework in the removal of anionic dyes from water (2021)
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis (2023)
A novel heteroleptic Cu(II)-phenanthroline-UDCA complex as lipoxygenase inhibitor and ER-stress inducer in cancer cell lines (2023)
Lékařská biologie II. Genetika a molekulární medicína (2023)
Laser ablation synthesis of tellurium carbides using tellurium with nanodiamond nanocomposite (2023)
Mass spectrometry for monitoring and quality control of differentiation of pluripotent stem cells to lung progenitors using biostatistical models (2023)
Biostatistics and data evaluation of intact cell MS application in stem cells and progenitors biotyping (2021)
Využití metod strojového učení a hmotnostní spektrometrie pro klinické aplikace v nádorové biologii (2023)
Serum spectral fingerprints reveal different forms of advanced multiple myeloma disease (2021)
ER-stress induce epithelial-to-mesenchymal transition in expandable lung epithelia derived from pluripotent stem cells (2023)
AI in cancer research: from histology to personalized medicine (2023)
Endoplasmic reticulum stress response of patient-derived pancreatic ductal adenocarcinoma cells (2023)
Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry (2023)
Biostatistic and machine learning in MALDI mass spectrometry research (2023)
Standard Operating Procedure: Mass spectrometry biotyping of peripheral blood plasma of monoclonal gammopathy patients (2023)
Standard Operating Procedure: Bioanalytical quality control of cGMP/ATMP-grade stem cells and progenitors (2023)
Ternary copper(ii) complexes of 1,10-phenanthroline and coumarin-based oxylacetates as pro-apoptotic UPR CHOP inducers (2023)
Vývoj ex-vivo buněčných modelů pro studium heterogenity adenokarcinomu pankreatu (2023)
Guide to General Histology and Microscopic Anatomy (2023)
Nový cíl specifické protinádorové léčby mnohočetného myelomu - endoplazmatické retikulum a jeho signální dráhy (2023)
Laser ablation synthesis of tellurium clusters (2022)
Experimental Setup for Laser Ablation Synthesis of Nanoparticles (2023)
Utility of RNA sequencing for transcriptome analysis of small extracellular vesicles derived from blood sera of colorectal cancer patients (2023)
Intact cell mass spectrometry coupled with machine learning reveals minute changes induced by single gene silencing. (2024)
Pulsed laser ablation synthesis of fresh Te nanoparticles for matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) applications (2024)
Laser ablation synthesis of fresh Te nanoparticles for MALDI MS applications (2023)
The Use Of Maldi Tof Mass Spectrometers As A Kind Of Synthesizer For Laser Ablation Synthesis Of Tellurium Nanoparticles, Various Mixed Clusters And Their Simultaneous Characterization And Analysis (2023)
Laser Ablation Synthesis Of Te Nanoparticles And Their Characterization (2023)
Molekulární a funkční charakterizace exozómů a exozomálních dlouhých nekódujících RNA u pacientů s kolorektálním karcinomem (2023)
Ex-vivo 3D cellular models of pancreatic ductal adenocarcinoma: from embryonic development to precision oncology (2024)
Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients (2024)
Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease (2024)
2. Offsite Meeting of the Department of Histology and Embryology (ÚHE): Advancing Science and Collaboration (2024)
Metabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability (2024)
Dysregulation of microRNA among multiple myeloma, extramedullary disease, and plasma cell leukemia patients (2023)
Dysregulation of microRNA in Waldenström macroglobulinemia (2024)
Circulating plasma cells in multiple myeloma (2024)
Del(1p32) is an early and high-risk event in relapsed multiple myeloma patients with extraosseous plasmacytomas (2024)
Discriminating fingerprints of chronic neuropathic pain following spinal cord injury using artificial neural networks and mass spectrometry analysis of female mice serum (2024)
EL(1P32) IS AN EARLY AND HIGHRISK EVENT IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH EXTRAOSSEOUS PLASMACYTOMAS (2024)
CIRCULATING TUMOR CELLS HAVE HIGH PROGNOSTIC SIGNIFICANCE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH PARASKELETAL OR EXTRAMEDULLARY PLASMACYTOMAS (2024)
EXPRESSION PROFILING OF MICRORNAS ENRICHED IN SMALL EXTRACELLULAR VESICLES ISOLATED FROM PLASMA OF BONE MARROW OF MULTIPLE MYELOMA AND EXTRAMEDULLARY DISEASE (2024)
Optické mapování genomu a jeho přínos v diagnostice mnohočetného myelomu (2024)
Del(1p32) is an early and high-risk event in relapsed multiple myeloma patients with extraosseous plasmacytomas (2024)

Odebrat vše z výběru

Operace s vybranými výsledky

Export a tisk
Seznam vybraných záznamů

Vyhledávání publikací

Vybrané publikace/výsledky

Operace s vybranými výsledky

Další aplikace